INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

24,511 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
3,056 sh
Sep 8, 2026
Page 155 of 613
← PrevNext →
Sep 9, 2026
traded Sep 8, 2026
+1d
SEC Form 4

Evidence

11
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$206K
4,758 sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.52M
36.0K sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.67M
37.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
3,000 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

7
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$17K
46 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

3
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$8,055
23 sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

56
SA
Stamler David AllenDirector, Chief Executive Officer
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

56
MA
Marks Peter AshleyDirector
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

56
CL
Cheng LawrenceDirector
GMEGameStop Corp.
Open-market purchase
BUY$1.03M
55.0K sh
Sep 8, 2026Sep 8, 2026
traded Sep 8, 2026
+0dSEC Form 4

Evidence

52
MA
Marks Peter AshleyDirector
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

51
SR
Speth RalfDirector
SHMDSCHMID Group N.V.
Open-market purchase
BUY$114K
35.0K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

51
RW
Roeder Clinton WilliamChief Financial Officer
TISITEAM INC
Open-market purchase
BUY$221K
8,000 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

48
MJ
Meyer-Gloeckner Birger JohannesDirector
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$44K
1,531 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

46
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$1.60M
900.0K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

46
WJ
Wambeke David J.Chief Business Officer
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Open-market purchase
BUY$67K
33.3K sh
Aug 27, 2026Sep 8, 2026
traded Aug 27, 2026
+12dSEC Form 4

Evidence

43
SR
Speth RalfDirector
SHMDSCHMID Group N.V.
Open-market purchase
BUY$101K
33.0K sh
Sep 2, 2026Sep 8, 2026
traded Sep 2, 2026
+6dSEC Form 4

Evidence

42
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Open-market purchase
BUY$4.11M
54.3K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

41
BW
Bradford Tonya WilliamsDirector
LOBLive Oak Bancshares, Inc.
Open-market sale
SELL$64K
1,600 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

38
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Open-market purchase
BUY$1.20M
15.7K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

36
CR
Courtney Mark RVice President of Supply Chain
KTCCKEY TRONIC CORP
Open-market sale
SELL$1,324
566 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

36
AL
Agress Adam LEVP Business Development
KTCCKEY TRONIC CORP
Open-market sale
SELL$2,602
1,112 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

36
MF
Musa FernandoDirector
PCTPureCycle Technologies, Inc.
Open-market purchase
BUY$99K
15.5K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

36
VG
Voorhees Anthony GeneEVP-Admin, CFO, Treasurer
KTCCKEY TRONIC CORP
Open-market sale
SELL$3,283
1,403 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

34
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$251K
80.8K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

33
GJ
Grayson Blake JeffreyChief Financial Officer
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$2.10M
30.0K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

32
BD
Berho Carranza DiegoChief Portfolio Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$22K
6,219 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

32
SM
Sever MichalCMO
NYAXNayax Ltd.
Open-market sale
SELL$1,779
34 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

32
MF
McLaughlin Matthew F.Director, Chief Executive Officer
SCORCOMSCORE, INC.
Open-market purchase
BUY$84K
16.6K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

31
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$255K
9,705 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

31
PM
Prosor MayaChief Business Officer
LMNDLemonade, Inc.
Open-market sale
SELL$57K
1,040 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

31
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Open-market sale
SELL$249K
5,666 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

30
Mike KellyRSpouse
MDMississippi St Ref Go P/R 10/1/27 5% due 10/1/31
Sale
SELL$50K – $100KAug 17, 2026Sep 8, 2026
traded Aug 17, 2026
+22dHouse PTR

Evidence

30
Mike KellyRSpouse
NDNew Jersey St 19 GO Emer Go 5% due 6/1/28
Sale
SELL$50K – $100KAug 28, 2026Sep 8, 2026
traded Aug 28, 2026
+11dHouse PTR

Evidence

29
GS
Greenberg Aaron SamuelCSO
NYAXNayax Ltd.
Open-market sale
SELL$4,028
77 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

29
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$6,444
123 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

29
FL
Furman Carly LisanneCEO NAYX North America
NYAXNayax Ltd.
Open-market sale
SELL$5,022
96 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

28
CS
Courtis Kenneth S.Director
AMRAlpha Metallurgical Resources, Inc.
Open-market purchase
BUY$475K
2,109 sh
Sep 8, 2026Sep 8, 2026
traded Sep 8, 2026
+0dSEC Form 4

Evidence

28
CS
Courtis Kenneth S.Director
AMRAlpha Metallurgical Resources, Inc.
Open-market purchase
BUY$622K
2,749 sh
Sep 8, 2026Sep 8, 2026
traded Sep 8, 2026
+0dSEC Form 4

Evidence

28
CS
Courtis Kenneth S.Director
AMRAlpha Metallurgical Resources, Inc.
Open-market purchase
BUY$656K
2,891 sh
Sep 8, 2026Sep 8, 2026
traded Sep 8, 2026
+0dSEC Form 4

Evidence